A 48-year-old woman with chronic alcohol use disorder is found to have hepatomegaly and mildly elevated transaminases on routine screening. She is asymptomatic with no clinical signs of cirrhosis. Which investigation is most appropriate as the next step to assess the degree of hepatic fibrosis and guide management decisions?

Explanation

## Non-Invasive Assessment of Hepatic Fibrosis **Key Point:** Transient elastography (FibroScan) is the most appropriate first-line non-invasive investigation for assessing fibrosis stage in asymptomatic patients with suspected early-stage alcoholic liver disease. ### Transient Elastography (FibroScan) — Advantages 1. **Non-invasive** — no tissue sampling, no bleeding risk 2. **Rapid and reproducible** — can be performed in outpatient setting in <5 minutes 3. **Quantitative measurement** — provides liver stiffness measurement (LSM) in kilopascals (kPa) 4. **Fibrosis staging** — correlates with histological fibrosis grades: - LSM <6 kPa: F0–F1 (no/minimal fibrosis) - LSM 6–9 kPa: F1–F2 (mild fibrosis) - LSM 9–12 kPa: F2–F3 (significant fibrosis) - LSM >12 kPa: F3–F4 (advanced fibrosis/cirrhosis) 5. **Cost-effective** — cheaper than biopsy, repeatable for monitoring 6. **Guides management** — helps identify patients requiring closer surveillance or antiviral therapy **High-Yield:** FibroScan is now recommended as first-line for screening fibrosis in chronic liver disease by AASLD, EASL, and WHO guidelines. ### Limitations of FibroScan - Unreliable in obesity (BMI >30) and ascites - Cannot assess inflammation grade or exclude alternative diagnoses - Operator-dependent - Overestimates fibrosis in acute hepatitis **Clinical Pearl:** In asymptomatic patients with early-stage disease, FibroScan helps avoid unnecessary biopsy while providing prognostic information. If FibroScan shows advanced fibrosis (F3–F4), biopsy may be considered for confirmation and exclusion of other pathology. ### Comparison of Fibrosis Assessment Methods | Method | Invasiveness | Cost | Accuracy | Time | Repeatability | |--------|-------------|------|----------|------|---------------| | FibroScan | Non-invasive | Low | Moderate–High | <5 min | Excellent | | Serum markers | Non-invasive | Low | Moderate | <1 hr | Excellent | | Liver biopsy | Invasive | High | Gold standard | 1–2 hrs | Poor | | CT/MRI | Non-invasive | High | Moderate | 30–60 min | Good |